Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis

Metabolism: Clinical and Experimental

Volumn 65, Issue 6, 2016, Pages 825-834

  Qiu, Shanhu ^a   Cai, Xue ^a   Yin, Han ^a,b   Zügel, Martina ^b   Sun, Zilin ^a   Steinacker, Jürgen Michael ^b   Schumann, Uwe ^b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Insulin resistance; Irisin; Meta analysis

Indexed keywords

INSULIN; IRISIN; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT DISEASE; ARTICLE; BLOOD SAMPLING; DIABETES MELLITUS; DISEASE ASSESSMENT; ETHNIC DIFFERENCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SENSITIVITY INDEX; PRIORITY JOURNAL; QUALITY CONTROL; SEX DIFFERENCE; SYSTEMATIC REVIEW; ADULT; BLOOD; META ANALYSIS; PHYSIOLOGY;

ADULT; FIBRONECTINS; HUMANS; INSULIN RESISTANCE;

EID: 84961778466     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2016.02.006     Document Type: Article

References (58)

1. A.D. Anastasilakis, S.A. Polyzos, Z.G. Saridakis, G. Kynigopoulos, E.C. Skouvaklidou, D. Molyvas, and et al. Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition J Clin Endocrinol Metab 99 9 2014 3247 3255
2. P. Boström, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, and et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 481 7382 2012 463 468
3. S. Raschke, M. Elsen, H. Gassenhuber, M. Sommerfeld, U. Schwahn, B. Brockmann, and et al. Evidence against a beneficial effect of irisin in humans PLoS One 8 9 2013 e73680
4. E. Albrecht, F. Norheim, B. Thiede, T. Holen, T. Ohashi, L. Schering, and et al. Irisin - a myth rather than an exercise-inducible myokine Sci Rep 5 2015 8889
5. F. Sanchis-Gomar, R. Alis, and G. Lippi Circulating irisin detection: does it really work? Trends Endocrinol Metab 26 7 2015 335 336
6. M.P. Jedrychowski, C.D. Wrann, J.A. Paulo, K.K. Gerber, J. Szpyt, M.M. Robinson, and et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry Cell Metab 22 4 2015 734 740
7. S.A. Polyzos, and C.S. Mantzoros An update on the validity of irisin assays and the link between irisin and hepatic metabolism Metabolism 64 9 2015 937 942
8. P. Lee, J.D. Linderman, S. Smith, R.J. Brychta, J. Wang, C. Idelson, and et al. Risin and FGF21 are cold-induced endocrine activators of brown fat function in humans Cell Metab 19 2 2014 302 309
9. Y. Zhang, R. Li, Y. Meng, S. Li, W. Donelan, Y. Zhao, and et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 map kinase and erk map kinase signaling Diabetes 63 2 2014 514 525
10. H. Jeong Lee, J. Ok Lee, N. Kim, J. Kwan Kim, H. Ip Kim, Y. Woo Lee, and et al. Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via ampk Mol Endocrinol 29 6 2015 873 881
11. K.H. Park, L. Zaichenko, M. Brinkoetter, B. Thakkar, A. Sahin-Efe, K.E. Joung, and et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome J Clin Endocrinol Metab 98 12 2013 4899 4907
12. M. Li, M. Yang, X. Zhou, X. Fang, W. Hu, W. Zhu, and et al. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome J Clin Endocrinol Metab 100 4 2015 1485 1493
13. M. Moreno, J.M. Moreno-Navarrete, M. Serrano, F. Ortega, E. Delgado, C. Sanchez-Ragnarsson, and et al. Circulating irisin levels are positively associated with metabolic risk factors in sedentary subjects PLoS One 10 4 2015 e0124100
14. A.E. Huerta, P.L. Prieto-Hontoria, M. Fernandez-Galilea, N. Sainz, M. Cuervo, J.A. Martinez, and et al. Circulating irisin and glucose metabolism in overweight/obese women: effects of alpha-lipoic acid and eicosapentaenoic acid J Physiol Biochem 71 3 2015 547 558
15. J.Y. Huh, G. Panagiotou, V. Mougios, M. Brinkoetter, M.T. Vamvini, B.E. Schneider, and et al. Fndc5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and ii. mRNA expression and circulating concentrations in response to weight loss and exercise Metabolism 61 12 2012 1725 1738
16. C.L. Chang, S.Y. Huang, Y.K. Soong, P.J. Cheng, C.J. Wang, and I.T. Liang Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome J Clin Endocrinol Metab 99 12 2014 E2539 E2548
17. H.J. Hirsch, I. Gross, Y. Pollak, T. Eldar-Geva, and V. Gross-Tsur Irisin and the metabolic phenotype of adults with Prader-Willi syndrome PLoS One 10 9 2015 e0136864
18. J.Q. Chen, Y.Y. Huang, A.M. Gusdon, and S. Qu Irisin: a new molecular marker and target in metabolic disorder Lipids Health Dis 14 1 2015 2
19. T. Hofmann, U. Elbelt, and A. Stengel Irisin as a muscle-derived hormone stimulating thermogenesis - a critical update Peptides 54 2014 89 100
20. M.F. Garces, J.J. Peralta, C.E. Ruiz-Linares, A.R. Lozano, N.E. Poveda, A.L. Torres-Sierra, and et al. Irisin levels during pregnancy and changes associated with the development of preeclampsia J Clin Endocrinol Metab 99 6 2014 2113 2119
21. The Cochrane Collaboration Cochrane handbook for systematic reviews of interventions version 5.1.0 [article online] 2011 Available from http://www.cochrane-handbook.org [Accessed 30 December 2015]
22. S. Qiu, X. Cai, X. Chen, B. Yang, and Z. Sun Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials BMC Med 12 2014 36
23. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, J.P. Vandenbroucke, and et al. The strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies Int J Surg 12 12 2014 1495 1499
24. C.-W.C. Lin, J.H. McAuley, L. Macedo, D.C. Barnett, R.J. Smeets, and J.A. Verbunt Relationship between physical activity and disability in low back pain: a systematic review and meta-analysis Pain 152 3 2011 607 613
25. A. Muezzinler, A.K. Zaineddin, and H. Brenner Body mass index and leukocyte telomere length in adults: a systematic review and meta-analysis Obes Rev 15 3 2014 192 201
26. F.H. Rizk, S.A. Elshweikh, and A.Y. Abd El-Naby Irisin levels in relation to metabolic and liver functions in Egyptian patients with metabolic syndrome Can J Physiol Pharmacol 2015 [Epub ahead of print]
27. I. Gouni-Berthold, H.K. Berthold, J.Y. Huh, R. Berman, N. Spenrath, W. Krone, and et al. Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo PLoS One 8 9 2013 e72858
28. J.J. Liu, M.D.S. Wong, W.C. Toy, C.S.H. Tan, S. Liu, X.W. Ng, and et al. Lower circulating irisin is associated with type 2 diabetes mellitus J Diabetes Complications 27 4 2013 365 369
29. D. Loffler, U. Muller, K. Scheuermann, D. Friebe, J. Gesing, J. Bielitz, and et al. Serum irisin levels are regulated by acute strenuous exercise J Clin Endocrinol Metab 100 4 2015 1289 1299
30. S. Pekkala, P.K. Wiklund, J.J. Hulmi, J.P. Ahtiainen, M. Horttanainen, E. Pollanen, and et al. Are skeletal muscle fndc5 gene expression and irisin release regulated by exercise and related to health? J Physiol 591 Pt 21 2013 5393 5400
31. P.R. Peter, K.H. Park, J.Y. Huh, N.M. Wedick, and C.S. Mantzoros Circulating irisin levels are not affected by coffee intake: a randomized controlled trial PLoS One 9 4 2014 e94463
32. G. Sesti, F. Andreozzi, T.V. Fiorentino, G.C. Mannino, A. Sciacqua, M.A. Marini, and et al. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects Acta Diabetol 51 5 2014 705 713
33. K. Tanisawa, H. Taniguchi, X. Sun, T. Ito, Z.-B. Cao, S. Sakamoto, and et al. Common single nucleotide polymorphisms in the fndc5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels Metabolism 63 4 2014 574 583
34. C. Huth, M.-J. Dubois, A. Marette, A. Tremblay, S.J. Weisnagel, M. Lacaille, and et al. Irisin is more strongly predicted by muscle oxidative potential than adiposity in non-diabetic men J Physiol Biochem 71 3 2015 559 568
35. K.H. Park, L. Zaichenko, P. Peter, C.R. Davis, J.A. Crowell, and C.S. Mantzoros Diet quality is associated with circulating C-reactive protein but not irisin levels in humans Metabolism 63 2 2014 233 241
36. F. Norheim, T.M. Langleite, M. Hjorth, T. Holen, A. Kielland, H.K. Stadheim, and et al. The effects of acute and chronic exercise on pgc-1alpha, irisin and browning of subcutaneous adipose tissue in humans FEBS J 281 3 2014 739 749
37. A.B. Crujeiras, M. Pardo, R.R. Arturo, S. Navas-Carretero, M.A. Zulet, J.A. Martinez, and et al. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women Am J Hum Biol 26 2 2014 198 207
38. A. Viitasalo, M. Atalay, J. Pihlajamaki, J. Jaaskelainen, A. Korkmaz, D. Kaminska, and et al. The 148 M allele of the PNPLA3 is associated with plasma irisin levels in a population sample of Caucasian children: the PANIC study Metabolism 64 7 2015 793 796
39. G.R. Steinberg, B.J. Michell, B.J. van Denderen, M.J. Watt, A.L. Carey, B.C. Fam, and et al. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling Cell Metab 4 6 2006 465 474
40. J.J. Senn, P.J. Klover, I.A. Nowak, and R.A. Mooney Interleukin-6 induces cellular insulin resistance in hepatocytes Diabetes 51 12 2002 3391 3399
41. K. Tanigaki, W. Vongpatanasin, J.A. Barrera, D.N. Atochin, P.L. Huang, E. Bonvini, and et al. C-reactive protein causes insulin resistance in mice through fcgamma receptor iib-mediated inhibition of skeletal muscle glucose delivery Diabetes 62 3 2013 721 731
42. S. Qiu, X. Cai, U. Schumann, M. Velders, Z. Sun, and J.M. Steinacker Impact of walking on glycemic control and other cardiovascular risk factors in type 2 diabetes: a meta-analysis PLoS One 9 10 2014 e109767
43. M. Pardo, A.B. Crujeiras, M. Amil, Z. Aguera, S. Jimenez-Murcia, R. Banos, and et al. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index Int J Endocrinol 2014 2014 857270
44. K.E. Joung, K.-H. Park, L. Zaichenko, A. Sahin-Efe, B. Thakkar, M. Brinkoetter, and et al. Early life adversity is associated with elevated levels of circulating leptin, irisin, and decreased levels of adiponectin in midlife adults J Clin Endocrinol Metab 99 6 2014 E1055 E1060
45. M. Eleftheriadou, L. Michala, K. Stefanidis, I. Iliadis, A. Lykeridou, and A. Antsaklis Exercise and sedentary habits among adolescents with PCOS J Pediatr Adolesc Gynecol 25 3 2012 172 174
46. C. Medina, I. Janssen, I. Campos, and S. Barquera Physical inactivity prevalence and trends among Mexican adults: results from the National Health and Nutrition survey (ENSANUT) 2006 and 2012 BMC Public Health 13 2013 1063
47. P. Lopez-Legarrea, R. de la Iglesia, A.B. Crujeiras, M. Pardo, F.F. Casanueva, M.A. Zulet, and et al. Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects Nutr Diabetes 4 2014 e110
48. H. Ghanim, S. Abuaysheh, C.L. Sia, K. Korzeniewski, A. Chaudhuri, J.M. Fernandez-Real, and et al. Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance Diabetes Care 32 12 2009 2281 2287
49. S.M. Haffner, M.P. Stern, B.D. Mitchell, H.P. Hazuda, and J.K. Patterson Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution Diabetes 39 3 1990 283 288
50. S.A. Polyzos, J. Kountouras, A.D. Anastasilakis, E.V. Geladari, and C.S. Mantzoros Irisin in patients with nonalcoholic fatty liver disease Metabolism 63 2 2014 207 217
51. S.A. Polyzos, J. Kountouras, K. Shields, and C.S. Mantzoros Irisin: a renaissance in metabolism? Metabolism 62 8 2013 1037 1044
52. C. Zhang, Z. Ding, G. Lv, J. Li, P. Zhou, and J. Zhang Lower irisin level in patients with type 2 diabetes mellitus: a case-control study and meta-analysis J Diabetes 8 1 2016 56 62
53. L. Xiang, G. Xiang, L. Yue, J. Zhang, and L. Zhao Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy Atherosclerosis 235 2 2014 328 333
54. M. Kasuga Insulin resistance and pancreatic beta cell failure J Clin Invest 116 7 2006 1756 1760
55. H.Y. Choi, S. Kim, J.W. Park, N.S. Lee, S.Y. Hwang, J.Y. Huh, and et al. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans J Clin Endocrinol Metab 99 8 2014 2778 2785
56. N.M. Al-Daghri, K.M. Alkharfy, S. Rahman, O.E. Amer, B. Vinodson, S. Sabico, and et al. Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects Eur J Clin Invest 44 2 2014 119 124
57. F. Sanchis-Gomar, R. Alis, H. Pareja-Galeano, M. Romagnoli, and C. Perez-Quilis Inconsistency in circulating irisin levels: what is really happening? Horm Metab Res 46 8 2014 591 596
58. E.F. Schisterman, S.R. Cole, and R.W. Platt Overadjustment bias and unnecessary adjustment in epidemiologic studies Epidemiology 20 4 2009 488 495